| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/08/2004 | CA2508273A1 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | CA2502138A1 Therapeutic applications of 2-substituted 4-heteroarylryrimidines |
| 07/07/2004 | EP1435356A1 Quinoline derivatives as CRTH2 antagonists |
| 07/07/2004 | EP1435353A1 Novel heterocyclic compound and anti-inflammatory agent |
| 07/07/2004 | EP1434990A2 Method for identifying compounds the specifically deplete mast cells |
| 07/07/2004 | EP1434886A2 Mid 241 receptor, a novel g-protein coupled receptor |
| 07/07/2004 | EP1434885A2 21132, a human g-protein coupled receptor family member and uses therefor |
| 07/07/2004 | EP1434860A2 Enzymes |
| 07/07/2004 | EP1434798A2 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells |
| 07/07/2004 | EP1434796A2 Secreted proteins |
| 07/07/2004 | EP1434792A2 Peptidyl ketones as inhibitors of dpiv |
| 07/07/2004 | EP1434791A2 Specific binding agents of human angiopoietin-2 |
| 07/07/2004 | EP1434788A2 Proteins associated with cell growth, differentiation, and death |
| 07/07/2004 | EP1434785A2 Protein modification and maintenance molecules |
| 07/07/2004 | EP1434777A1 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434774A1 3-(4-substituted heterocyclyl)-pyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 07/07/2004 | EP1434772A1 Compounds and methods |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434624A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 07/07/2004 | EP1434599A1 Human 3 relaxin |
| 07/07/2004 | EP1434594A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 07/07/2004 | EP1434591A1 Use of fly larvae extracts for the treatment of wounds |
| 07/07/2004 | EP1434590A2 Method for inhibiting the formation of seromas using factor xiii |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | EP1434582A2 Topical composition containing brucine and the use for the treatment of damaged mammalian skin |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434565A2 Use of ganoderic acids as cosmetic agents and for treating or preventing skin disorder and corresponding composition |
| 07/07/2004 | EP1434559A1 Cosmetic and/or pharmaceutical preparations |
| 07/07/2004 | EP1434558A1 Cosmetic and/or pharmaceutical superfatting preparations |
| 07/07/2004 | EP1434556A1 Cosmetic and/or pharmaceutical preparations |
| 07/07/2004 | EP1242404B1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 07/07/2004 | EP1073435B1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 07/07/2004 | EP1047694B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/07/2004 | EP0759749B1 Anti-acne compositions |
| 07/07/2004 | CN1511159A Nitrogen-based camptothecin derivatives |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511053A HSA-free formulations of interferon-Beta |
| 07/07/2004 | CN1511017A Treating epidermlyosis bullosa with thymosin Beta-4 |
| 07/07/2004 | CN1509752A Medicine for treating skin chap, and preparing method thereof |
| 07/07/2004 | CN1509716A Application of oxidative matridine in antipruritic medicine |
| 07/07/2004 | CN1509706A Chinese medicinal skin-beautifying honey and preparing method thereof |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156477C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 07/07/2004 | CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156305C Chinese-medical oinment for treating burn |
| 07/07/2004 | CN1156301C Ointment for treating burn and scald and its preparing process |
| 07/07/2004 | CN1156293C Tea Leaf-seed ointment for treating scald and its preparing process |
| 07/07/2004 | CN1156274C Medicinal ointment containing zinc conjugated linoleate and sodium humate |
| 07/06/2004 | US6759557 Macrocyclic hydrocarbon rings with hydroxyl and/or ketone functionalities, such as cyclotetradecanone or 2-hydroxycyclohexadecanone, optionally with skin whitening agents and/or uv absorbers |
| 07/06/2004 | US6759547 Reduces serum glucose and serum triglyceride levels in diabetic mammals without the undesirable properties of reducing serum thyroxine levels and transiently raising triglyceride levels |
| 07/06/2004 | US6759535 A 3-amide-methyl- or 3-urea-isoquinoline derivatives, enzyme inhibitor of protein kinase, for treating cell proliferation, cell death, inflammatory diseases, autoimmune diseases, bone disorders, infectious diseases, viral diseases |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759396 Compositions based on a synergistic mixture of at least one VDR ligand and a retinoid |
| 07/06/2004 | US6759389 Purified recombinant protein consisting of amino acid sequence 3; axonal regeneration; accelerating wound healing while minimizing scar tissue and keloid formation keloid formation. |
| 07/06/2004 | US6759387 Delivery enhancing transporter that has sufficient guanidino or amidino sidechain moieties to enhance delivery of a compound conjugated to the reagent across one or more layers of the tissue |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |
| 07/06/2004 | US6759194 Nucleotide sequences encoding peroxisome-associated polypeptides, and their uses in the diagnosis and/or treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 07/06/2004 | US6759065 Extraction method, pharmaceutical composition and a cosmetic composition |
| 07/06/2004 | US6759051 Cosmetic or dermatological composition comprising at least one alkynyl carbamate and at least one polyol |
| 07/06/2004 | CA2433080C Stable enzymatic wound debrider |
| 07/06/2004 | CA2303594C Compounds for treating and preventing diabetic complications |
| 07/06/2004 | CA2243715C Method for reducing skin oils and grease |
| 07/01/2004 | WO2004055009A1 Novel compounds having selective inhibiting efect at gsk3 |
| 07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004055005A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004054996A1 New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor |
| 07/01/2004 | WO2004054989A1 Novel 2,4-diamino-1,3,5-triazine derivative |
| 07/01/2004 | WO2004054977A1 Nicotinamide-based kinase inhibitors |
| 07/01/2004 | WO2004054616A1 Antagonist and agonist binding to strong binding site of chemokine receptor |
| 07/01/2004 | WO2004054598A1 Use of plant extract of the family of clusiaceae for preparing a composition for treating or preventing greasy skin-mediated disorders |
| 07/01/2004 | WO2004054588A1 Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate |
| 07/01/2004 | WO2004054577A1 Alpha-2-delta ligands to treat ocd and related diseases |
| 07/01/2004 | WO2004054563A1 Alpha-2-delta ligand for the treatment of sexual dysfunction |
| 07/01/2004 | WO2004054559A1 Alpha2delta ligands for different pharmaceutical uses |
| 07/01/2004 | WO2004054533A1 Use of an alkyl ether of hydroxystilbene for the treatment of dry skin |
| 07/01/2004 | WO2004054520A1 Whitening agent, skin preparation for external use and cosmetic |
| 07/01/2004 | WO2004041859A3 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/01/2004 | WO2004029025A3 Methods and compositions for the treatment of autoimmune disorders using clofarabine |
| 07/01/2004 | WO2004016612A3 New purine derivatives |
| 07/01/2004 | WO2004002420A3 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 07/01/2004 | WO2003093297A3 Protein kinase modulators and methods of use |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | WO2003040366A3 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | WO2002015846A3 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 07/01/2004 | US20040127826 Honey in wound dressings |
| 07/01/2004 | US20040127712 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 07/01/2004 | US20040127707 Novel phthalazinones |